Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation
Completed
Conditions studied: Malignant Solid Tumor, Hematologic Malignancies
In brief
The primary objective of this study is to establish the feasibility and value of physical fitness assessment within patients receiving cytotoxic chemotherapy. If successful, this project will establish the groundwork for physical function assessment in larger cancer clinical trials to assist patient selection and evaluation of toxicity and/or response among trial participants.
Key facts
- Study ID
- NCT02844400
- Run by
- UNC Lineberger Comprehensive Cancer Center
- People needed
- 67
- Starts
- 2016-11-01
- Expected to finish
- 2018-12-01
- Last updated by the study team
- 2019-02-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients receiving cytotoxic chemotherapy with at least a 3 week cycle (either adjuvant/curative or palliative)
- Age ≥ 18, prioritizing patients ≥ 60 years
- At least 6 weeks out from surgical resection
- Presence of working email address
- Access to internet at home and either access to wireless internet or cellular data reception
- Ability to read and understand English
- Ability to understand and comply with study procedures
You may not qualify if…
- Dementia, altered mental status, or psychiatric condition that would prohibit the understanding or rendering of informed consent
- Contraindication to CPET per standard American Thoracic Society (ATS) guidelines
Where it is running
- Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.